Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?: Evidences, unresolved questions and a practical algorithm.

Pons-Tostivint, E; Alouani, E; Kirova, Y; Dalenc, F; Vaysse, C

Pons-Tostivint, E; Alouani, E; Kirova, Y; Dalenc, F; Vaysse, C.

Afiliación

Pons-Tostivint E; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France. Electronic address: elvire.pons-tostivint@inserm.fr.
Alouani E; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.
Kirova Y; Department of Radiation Therapy, Institut Curie, Paris, France.
Dalenc F; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.
Vaysse C; Surgical Department, Toulouse University Hospital Center (CHU Toulouse), IUCT-Oncopole, 31000, Toulouse, France.

Crit Rev Oncol Hematol ; 157: 103146, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33227574

Asunto(s)

Neoplasias de la Mama; Algoritmos; Neoplasias de la Mama/terapia; Humanos; Estudios Prospectivos; Estudios Retrospectivos; Tasa de Supervivencia

Palabras clave

De novo metastatic breast cancer; Exclusive radiotherapy; Locoregional treatment; Primary tumor; Surgery; Tumor biology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google